Properly timed injections of cortisol and prolactin produce long-term reductions in obesity, hyperinsulinaemia and insulin resistance in the Syrian hamster (Mesocricetus auratus)
- PMID: 2647890
- DOI: 10.1677/joe.0.1200385
Properly timed injections of cortisol and prolactin produce long-term reductions in obesity, hyperinsulinaemia and insulin resistance in the Syrian hamster (Mesocricetus auratus)
Abstract
Naturally obese female Syrian hamsters were injected daily with prolactin at 0 or 12 h after cortisol injections for 10 days while held in constant light. Controls were similarly injected with saline. Animals were then held on short daylengths (10 h light:14 h darkness) for 10 weeks. They were allowed free access to food and water from birth to time of death. Ten weeks after treatment, retroperitoneal fat stores, plasma concentrations of insulin and glucose, and hypoglycaemic responsiveness to exogenous insulin were determined. The control groups as well as the 12-h hormone treatment group were obese, hyperinsulinaemic and insulin resistant. However, the 0-h treatment dramatically reduced retroperitoneal fat stores (41-55%), plasma insulin concentration (60-70%) and the insulin to glucose ratio (63-68%) compared with controls. Values for these parameters in the 0-h treatment groups were similar to those of their lean litter-mates. Furthermore, the 0-h group but not the 12-h group was more sensitive than control animals to the hypoglycaemic effects of exogenous insulin at doses 0.2 and 2.0 U/kg body weight. These results demonstrate that timed daily injections of cortisol and prolactin in specific temporal relationships can produce marked reductions in obesity, hyperinsulinaemia and insulin resistance in the Syrian hamster that persist long after the termination of treatment. This study also suggests an important role for the interactions of circadian neuroendocrine systems in the regulation of these metabolic states.
Similar articles
-
Circadian and seasonal variations of plasma insulin and cortisol concentrations in the Syrian hamster, Mesocricetus auratus.Chronobiol Int. 1987;4(2):141-51. doi: 10.3109/07420528709078520. Chronobiol Int. 1987. PMID: 3334220
-
Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus auratus.Metabolism. 1991 Jun;40(6):639-44. doi: 10.1016/0026-0495(91)90057-4. Metabolism. 1991. PMID: 1865827
-
Association of the antidiabetic effects of bromocriptine with a shift in the daily rhythm of monoamine metabolism within the suprachiasmatic nuclei of the Syrian hamster.Chronobiol Int. 2000 Mar;17(2):155-72. doi: 10.1081/cbi-100101040. Chronobiol Int. 2000. PMID: 10757461
-
Bromocriptine inhibits in vivo free fatty acid oxidation and hepatic glucose output in seasonally obese hamsters (Mesocricetus auratus).Metabolism. 1995 Oct;44(10):1349-55. doi: 10.1016/0026-0495(95)90041-1. Metabolism. 1995. PMID: 7476296
-
Bromocriptine redirects metabolism and prevents seasonal onset of obese hyperinsulinemic state in Syrian hamsters.Am J Physiol. 1993 Feb;264(2 Pt 1):E285-93. doi: 10.1152/ajpendo.1993.264.2.E285. Am J Physiol. 1993. PMID: 8447396
Cited by
-
Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet.Int J Mol Sci. 2021 Jun 7;22(11):6142. doi: 10.3390/ijms22116142. Int J Mol Sci. 2021. PMID: 34200262 Free PMC article.
-
Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.Int J Mol Sci. 2023 Aug 26;24(17):13255. doi: 10.3390/ijms241713255. Int J Mol Sci. 2023. PMID: 37686060 Free PMC article. Review.
-
Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats.Diabetol Metab Syndr. 2014 Sep 25;6:104. doi: 10.1186/1758-5996-6-104. eCollection 2014. Diabetol Metab Syndr. 2014. PMID: 25937836 Free PMC article.
-
Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome.Front Endocrinol (Lausanne). 2021 Feb 25;12:571229. doi: 10.3389/fendo.2021.571229. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33716958 Free PMC article.
-
Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabetics.Experientia. 1992 Mar 15;48(3):248-53. doi: 10.1007/BF01930467. Experientia. 1992. PMID: 1547854 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical